Ildong Pharmaceutical will be inevitable to have a voting challenge against Green Cross on the general meeting of shareholders
Triggered by the shareholder proposal of the 2nd largest shareholder of Ildong Pharmaceutical, Green Cross, the M&A conflict between the two companies will lead to voting.
Ildong Pharmaceutical held a board meeting on the 26th and decided to lay items to reappoint president Jung-chi Lee as its C...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
